Archean Chemical Industries Limited — Q3 FY26
Archean Chemical Industries reported a mixed Q3 FY26 with standalone revenue growing 12% YoY, but EBITDA declined 25% YoY to ₹69.9 crore, and PAT fell to ₹34.3 crore.
neutral
medium
✓ Verified against BSE filing
Claim Ledger
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
75%Questions answered2Evaded / deflected12Questions audited
Answered
Medium priority
Revenue and volumes for SOP in Q3
Asked by Sanjay Jen, ICICI Securities
Provided specific volume and revenue numbers for SOP.
Read the exchange
Question
can you repeat the revenue for Akums for Q3 SOP and volumes for both?
Natraan (unclear role)
Q3 is 71 metric tan. And value is 751. No no 7 71 71 71 71. Okay. And value is value is 32 lakhs.
Answered
High priority
Why bromine prices up but derivative under pressure?
Asked by Sanjay Jen, ICICI Securities
Explained that cost pressures are not fully passed through due to contract structure.
Read the exchange
Question
you mentioned that you are seeing pressure on the broine derivative but on the other side if I look at the bromine prices they have really shot up now both really doesn't add up
Unnamed management (likely CEO or COO)
the increase in broine prices obviously spring thoughts cost pressures on our bromine derivatives business. given the specific products we are making right now and the way the contracts are not all of the crossing is something we're going to pass through to our clients.
Answered
High priority
Backlog status and production issues for bromine
Asked by Sanjay Jen, ICICI Securities
Provided updated backlog figure and confirmed no cancellations.
Read the exchange
Question
last quarter we mentioned that we have a 10,000 metric ton of backlog. the production really not keeping up. wanted to understand how much of this backlog is with the lower pricing
Unnamed management
we shipped approximately 2 and a half thousand tons of that. So we have still around 6 and a half thousand tons in backlog. we've not seen a significant amount of cancellations there.
Answered
High priority
Why target only 25kt when capacity is 42kt?
Asked by Sanjay Jen, ICICI Securities
Explained that expansion to 42kt depends on derivative business growth.
Read the exchange
Question
So we had a capacity of 42. Why why are we targeting only 25 that there's a disconnect between the capacity we have and the production we are targeting?
Raj (likely Rajiv, management)
the capacity expansion will actually primarily happen between 25 and 42 in line with the capacity expansion in the derivative business.
Answered
High priority
Derivative volume drop and ramp-up plan for FY27
Asked by Sanjay Jen, ICICI Securities
Provided current utilization and target for next year.
Read the exchange
Question
there's a sharp drop in the volume how do we plan to ramp it up and I think we are lagging significantly in terms of what we thought we should do
Unnamed management
we are right around 35 to 40% utilization. first target for us is to get the utilization up. for 26 27 we are trying to scale it up to around 60 to 70% utilization at a plant level.
Evasive
High priority
Is there a management bandwidth issue causing delays?
Asked by Vin Nadkarnney, Hatway Investments Private Limited
Acknowledged delays but denied bandwidth issue without specifics.
denied bandwidth issueattributed to specific challenges
Read the exchange
Question
whether it is orin hydrocarbons whether it is bromine derivatives whether it is bromine also or SOP everything gets delayed as the quarters go by every time there is some kind of a delay that is happening is there any management bandwidth issue
Unnamed management
I don't think that would probably be an oversimplification of the issue. there specific challenges we've had. we have good bandwidth on the ground which is why we've been able to make these changes within one quarter.
Partial answer
High priority
Contract vs spot mix for bromine and when benefit of higher prices will show
Asked by Rohit Nag, 361 Capital
Gave approximate contract share but no precise timing of benefit.
no exact split givendeferred specific timing
Read the exchange
Question
how much is maybe a medium long-term contract and how much is F. whenever there is change in bromine prices whether we'll get that advantage or not
Unnamed management
we have around 6 and a half thousand tons of contracted backlog. we have a mix of both spot and contract prices. the longerterm contract should probably represent probably 50 to 60% of our volume.
Answered
High priority
Can bromine production reach at least 18,000 tons next year?
Asked by Rohit Nag, 361 Capital
Gave a clear affirmative answer.
Read the exchange
Question
next year given the constraints that we have on domain is there a fair chance of reaching at least the 18,000 tons of production
Unnamed management
Simple answer yes
Declined
Medium priority
Revenue guidance for Orin next year (100-150 crores?)
Asked by Rohit Nag, 361 Capital
Refused to provide revenue guidance for Orin.
no guidance policydeferred to next quarter
Read the exchange
Question
Orin we had indicated that there have been delays in terms of the revenues next year what is the reasonable number that we can put 100 crores 150 crores
Unnamed management
as a matter of rule we don't give guidance. on the orange side idealist side I probably defer that answering that question but if you can pick the thread on it next quarter I'll probably be able to give you a better insight.
Answered
High priority
Sustainability of 25kt bromine target given climate change impact
Asked by Adita Ketan, Smith's Institutional Equities
Provided a clear target and path to 25kt.
Read the exchange
Question
how many months or days of lost volumes we can build and what is the sustainability of the numbers which you have given of 25 KT
Unnamed management
we will be north of 18,000 tons next year. the goal is to get to a run rate of between 18 and 25,000 at which stage we obviously have to do some expansion work.
Answered
Medium priority
Is derivative demand weak due to high bromine prices or global muted demand?
Asked by Adita Ketan, Smith's Institutional Equities
Clarified that demand is not the issue; scaling specific products is.
Read the exchange
Question
is that also related to the higher broine prices because the feature stock prices are higher consequently the CBF and PTA synthesis prices are also higher which is where you might not been able to pass on or the demand itself like in the global world that is muted today
Unnamed management
medium to long-term demand on the derivative side is pretty good. Short-term demand across categories is also fairly stable and improving. Our challenge has been in scaling up the business in some of the specific products we make.
Partial answer
High priority
SOP trajectory and plant trial status
Asked by Duv Muchell, HDFC AMC
Provided qualitative progress but no quantitative trajectory.
no specific numberdeferred to after plant trials
Read the exchange
Question
as you're confident of the recovery in broine from next year also can you highlight how the SOP trajectory could be I understand it's still on the plant trial stage probably starting soon but some early trends
Unnamed management
pilot trials have been successful. the chemistry works. we have the plant scale trials somewhere in this quarter or early next quarter. hard for me right now to give a specific number.